Depression among centenarians and the oldest old: contributions of cognition and personality.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 2874734)

Published in Gerontology on January 26, 2010

Authors

Jennifer Margrett1, Peter Martin, John L Woodard, L Stephen Miller, Maurice MacDonald, Joan Baenziger, Ilene C Siegler, Adam Davey, Leonard Poon, Georgia Centenarian Study, S M Jazwinski, R C Green, M Gearing, W R Markesbery, M A Johnson, J S Tenover, W L Rodgers, D B Hausman, C Rott, J Arnold

Author Affiliations

1: Iowa State University, Ames, Iowa, USA.

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26

The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32

New frontiers in the future of aging: from successful aging of the young old to the dilemmas of the fourth age. Gerontology (2003) 3.59

Executive dysfunction and the course of geriatric depression. Biol Psychiatry (2005) 2.56

A new scale for the assessment of functional status in Alzheimer's disease and related disorders. J Gerontol (1989) 2.07

Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies. Annu Rev Gerontol Geriatr (2007) 1.85

Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatr (2006) 1.45

Prevalence and risk factors for depression in a longitudinal, population-based study including individuals in the community and residential care. Am J Geriatr Psychiatry (2007) 1.40

Symptoms of depression in the oldest old: a longitudinal study. J Gerontol B Psychol Sci Soc Sci (2001) 1.09

Personality traits and the reporting of affective disorder symptoms in depressed patients. J Affect Disord (2007) 1.01

Cerebrovascular risk factors, executive dysfunction, and depression in older primary care patients. Am J Geriatr Psychiatry (2006) 0.96

Mastery and neuroticism predict recovery of depression in later life. Am J Geriatr Psychiatry (2007) 0.95

Similarities and differences in depression among black and white nursing home residents. Am J Geriatr Psychiatry (2002) 0.94

Modifiable characteristics of a healthy lifestyle in U.S. older adults with or without frequent mental distress: 2003 Behavioral Risk Factor Surveillance System. Am J Geriatr Psychiatry (2007) 0.94

Predicting the changes in depressive symptomatology in later life: how much do changes in health status, marital and caregiving status, work and volunteering, and health-related behaviors contribute? J Aging Health (2007) 0.88

Cerebrovascular risk factors and subsequent depression in older general practice patients. J Affect Disord (2006) 0.80

Articles by these authors

Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology (2007) 12.42

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75

Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol (2001) 7.97

A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med (1992) 7.16

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med (2013) 6.70

Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 6.62

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA (1998) 6.49

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet (2004) 6.27

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34

The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94

Current versus historical population sizes in vertebrate species with high gene flow: a comparison based on mitochondrial DNA lineages and inbreeding theory for neutral mutations. Mol Biol Evol (1988) 4.89

Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34. Infect Immun (1978) 4.71

Demographic influences on mitochondrial DNA lineage survivorship in animal populations. J Mol Evol (1984) 4.40

Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA (1996) 4.40

Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci (1998) 4.19

Asset and Health Dynamics Among the Oldest Old: an overview of the AHEAD Study. J Gerontol B Psychol Sci Soc Sci (1997) 4.15

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology (1998) 4.01

Complications of gamma knife surgery for Parkinson disease. Arch Neurol (2001) 3.97

Definition and properties of disequilibrium statistics for associations between nuclear and cytoplasmic genotypes. Genetics (1987) 3.96

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med (2014) 3.86

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 3.85

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84

Positional asphyxia during law enforcement transport. Am J Forensic Med Pathol (1992) 3.81

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77

"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57

The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43

Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36

S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26

Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20

An intervention resembling caloric restriction prolongs life span and retards aging in yeast. FASEB J (2000) 3.19

Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17

Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA (2005) 2.97

The health care burden of acute chest pain. Heart (2005) 2.92

Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology (2002) 2.87

Chromosome-specific recombinant DNA libraries from the fungus Aspergillus nidulans. Nucleic Acids Res (1991) 2.76

Prognostic significance of signet ring gastric cancer. J Clin Oncol (2012) 2.70

A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med (2002) 2.62

Comparison of the nucleotide sequence of soybean 18S rRNA with the sequences of other small-subunit rRNAs. J Mol Evol (1985) 2.60

Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology (2007) 2.54

Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr (2000) 2.54

Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics (1999) 2.50

A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry (2004) 2.45

Impaired proteasome function in Alzheimer's disease. J Neurochem (2000) 2.44

Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med (2004) 2.44

Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics (1993) 2.39

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood (2012) 2.37

Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34

Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34

Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology (2005) 2.33

The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009) 2.33

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging (2001) 2.26

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23

Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22

The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20

Evidence for the involvement of a cytoplasmic factor in the aging of the yeast Saccharomyces cerevisiae. J Bacteriol (1989) 2.18

Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol (1993) 2.17

Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (1999) 2.16

Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16

Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15

Mono- through hexanucleotide composition of the Escherichia coli genome: a Markov chain analysis. Nucleic Acids Res (1987) 2.11

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma. N Engl J Med (2015) 2.10

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09

Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08

Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06

The effect of codon usage on the oligonucleotide composition of the E. coli genome and identification of over- and underrepresented sequences by Markov chain analysis. Nucleic Acids Res (1987) 2.02

Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01

First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00

Protein oxidation in the brain in Alzheimer's disease. Neuroscience (2001) 2.00

Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust (2007) 1.99

Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology (2002) 1.96

Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93

In vitro activation of the transcription of araBAD operon by araC activator. Proc Natl Acad Sci U S A (1974) 1.91

Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer Discov (2013) 1.90

C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J (2001) 1.89

Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89

Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. Am J Trop Med Hyg (1976) 1.89

Thyroglossal duct remnants. Preoperative evaluation and management. Arch Otolaryngol Head Neck Surg (1991) 1.88

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem (2005) 1.88

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86

Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology (1996) 1.85

Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies. Annu Rev Gerontol Geriatr (2007) 1.85

Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet (2007) 1.84

An ensemble method for identifying regulatory circuits with special reference to the qa gene cluster of Neurospora crassa. Proc Natl Acad Sci U S A (2002) 1.82

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.82

Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82

Preparation of extracts from yeast. Methods Enzymol (1990) 1.81

Risk factors for potentially harmful informal caregiver behavior. J Am Geriatr Soc (2005) 1.81

Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem (1999) 1.81

Systolic blood pressure, socioeconomic status, and biobehavioral risk factors in a nationally representative US young adult sample. Hypertension (2011) 1.80

Granular cell tumors of the central nervous system. J Neuropathol Exp Neurol (1973) 1.79